Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioAge Labs, Inc. (BIOA) had Revenue of $1.45M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$1.45M
Net Income	$-12.93M
Cost of Goods Sold	--
Gross Profit	$1.45M
Operating Expenses	$17.90M
Operating Income	$-16.45M
Non-Operating Income/Expense	$3.52M
Pre-Tax Income	$-12.93M
Normalized Pre-Tax Income	$-12.93M
Income after Taxes	$-12.93M
Income from Continuous Operations	$-12.93M
Consolidated Net Income/Loss	$-12.93M
Normalized Income after Taxes	$-12.93M
EBIT	$-16.45M
EBITDA	$-16.41M
Weighted-Average Shares Outstanding (Basic)	35.85M
Weighted-Average Shares Outstanding (Diluted)	35.85M
Earnings per Share (EPS) (Basic)	$-0.36
Earnings per Share (EPS) (Diluted)	$-0.36
Balance Sheet Financials
Current Assets	$324.81M
Property, Plant, and Equipment	$0.93M
Long-Term Assets	$19.03M
Total Assets	$343.84M
Current Liabilities	$23.74M
Long-Term Debt	$1.06M
Long-Term Liabilities	$6.94M
Total Liabilities	$30.67M
Common Equity	$313.17M
Tangible Shareholders Equity	$313.17M
Shareholders Equity	$313.17M
Common Shares Outstanding	35.85M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-17.36M
Cash Flow from Investing Activities	$-77.99M
Cash Flow from Financial Activities	$-1.50M
Beginning Cash	$354.35M
End Cash	$257.49M
Increase/Decrease in Cash	$-96.86M
Stock-Based Compensation	$2.95M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	13.68
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.00
Debt to Equity Ratio	0.02
Gross Margin	100.00%
Operating Margin	-1133.42%
EBIT Margin	-1133.42%
EBITDA Margin	--
Pre-Tax Profit Margin	-890.97%
Profit Margin	-890.97%
Free Cash Flow	$-17.79M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.00
Inventory Turnover	--
Receiveable Turnover	4.02
Days Sales in Receivables	22.39
Return on Equity	-4.13%
Return on Tangible Equity	-4.13%
Return on Assets	-3.76%
Return on Investments	-4.11%
Book Value Per Share	$8.74
Free Cash Flow per Share	$-0.50
Operating Cash Flow per Share	$-0.48

Data from Zacks Investment Research, Inc.